GSA Capital Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Buy |
+20,418
| New | +$565K | 0.04% | 836 |
|
|
2024
Q4 | – | Sell |
-10,729
| Closed | -$268K | – | 1824 |
|
|
2024
Q3 | $268K | Buy |
+10,729
| New | +$268K | 0.02% | 1278 |
|
|
2023
Q4 | – | Sell |
-63,216
| Closed | -$1.1M | – | 1718 |
|
|
2023
Q3 | $1.1M | Buy |
63,216
+28,468
| +82% | +$494K | 0.09% | 346 |
|
|
2023
Q2 | $489K | Buy |
34,748
+4,613
| +15% | +$64.9K | 0.05% | 754 |
|
|
2023
Q1 | $324K | Buy |
+30,135
| New | +$324K | 0.03% | 986 |
|
|
2022
Q1 | – | Sell |
-16,157
| Closed | -$190K | – | 1624 |
|
|
2021
Q4 | $190K | Buy |
+16,157
| New | +$190K | 0.02% | 1241 |
|
|
2020
Q4 | – | Sell |
-20,774
| Closed | -$318K | – | 1420 |
|
|
2020
Q3 | $318K | Buy |
+20,774
| New | +$318K | 0.05% | 690 |
|